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SUMMARY 
 
Old intact male dogs are often predisposed to benign prostatic hyperplasia. Both hypertrophy and hyperplasia of prostate 
gland occur due to hormonal influences. Clinical signs such as haematuria, stranguria and tenesmus are often associated with benign 
prostatic hyperplasia. A seven year-old local breed intact male dog was presented with a primary complaint of haematuria and 
stranguria. Diagnostic work-up conducted inclusive of complete blood count, serum biochemistry, urinalysis, abdominal radiograph, 
cystourethrography and abdominal ultrasonography. The dog was diagnosed with cystic benign prostatic hyperplasia. Prostatic 
omentalisation and castration were performed in this case.    
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INTRODUCTION 
 
Canine prostate gland is an androgen-dependent, 
ovoid in shape, and bi-lobed gland that encircles the 
urethra in a male dog (Johnston et al., 2000). It is the only 
accessory sex gland in a male dog, located caudal to the 
neck of urinary bladder in retroperitoneal cavity.  
Benign prostatic hyperplasia is a common age-
related disorder in intact male dogs. More than 80% of 
male dogs over the age of five year-old are affected with 
this disorder (Johnston et al., 2000). Alteration of the 
androgen to oestrogen ratio in intact male dogs will result 
in hyperplasia and hypertrophy of prostate cells, leading 
to development of benign prostatic hyperplasia (Smith, 
2008). Clinical signs associated with benign prostatic 
hyperplasia are haematuria, stranguria, urethral discharge 
and tenesmus (Johnston et al., 2000).  
Prostatic disorders in dogs may be treated with 
medical therapy, surgery, or a combination of both. This 
article focuses on prostatic disorders that are treated 
surgically and prostatic surgical procedures. 
 
CASE REPORT 
 
A seven year-old intact male local dog was 
presented with the primary complaint of chronic 
haematuria and stranguria. The dog was managed indoor 
with updated vaccination and deworming program. The 
dog was previously diagnosed with kidney disease 
approximately nine months ago by a private veterinarian. 
Clinical signs of haematuria and stranguria resolved after 
a long-term treatment of Rowatinex® (ROWA 
Pharmaceuticals Ltd., Ireland) which consists of essential 
oil. However, haematuria recurred six months after the 
medication was stopped. The persistent recurrent clinical 
sign of haematuria prompted the owner to present the dog 
to University Veterinary Hospital, University Putra 
Malaysia (UVH-UPM) for second opinion. 
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All the vital signs including temperature, pulse, and 
respiration were within the normal range. The dog had a 
pink mucous membrane with capillary refill time of less 
than 2 seconds. There were bilateral submandibular lymph 
nodes slightly enlargement upon palpation. Trans-rectal 
palpation performed revealed an enlarged symmetry bump 
ventral to the rectum at the pelvic region. The differential 
diagnoses were benign prostatic hyperplasia, prostatic 
cyst, cystitis, cystolithiasis, urolithiasis and urinary 
bladder neoplasia. 
Blood obtained for a complete blood count revealed 
non-significant finding as all the parameters were within 
the normal range. Blood for serum biochemistry revealed 
slightly increased in calcium (2.94 mmol/L; normal range: 
2.0 to 2.8 mmol/L) and total protein (77.7 g/L; normal 
range: 55 to 75 g/L) level. Urine sample collected via 
spontaneous micturition method revealed hyperstenuric 
with the specific gravity (S.G.) of 1.050 (normal range: > 
1.030), suggestive highly concentrated urine. Microscopic 
evaluation of the urine sample had shown an evidence of 
red blood cells in the urine with five to ten erythrocytes 
per high power field. Other than that, the dog had slight 
proteinuria (Protein: 2+), bilirubinuria (Bilirubin: 2+), and 
increased turbidity (Turbidity: 2+) due to the presence of 
cells, casts, and crystals in the urine. Therefore the 
diagnosis of chronic kidney disease in this dog was not 
likely. 
Abdominal radiograph revealed that there were two 
oval radiopaque structures on caudal region of the 
abdominal cavity (Figure 1). The spleen was noted to be 
enlarged suggestive of splenomegaly. Further diagnosis 
workout of splenomegaly was not looked into in this case. 
These radiopaque structures were suspected to be the 
urinary bladder and the prostate gland. 
Cystourethrography was performed to differentiate the 
two radiopaque structures. The urinary bladder (red 
arrow) was filled with the contrast medium and appeared 
radiopaque in the cystourethrogram (Figure 2) with no 
filling defect. The other oval structure caudal to the 
urinary bladder was identified as the prostate gland (blue 
arrow). Urolith and cystolith were not noticed in the lower  
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Figure 1. Left lateral view of abdominal radiograph 
revealed two oval radiopaque structures on caudal 
region of the abdominal cavity (arrow). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Cystourethrogram of urinary was 
performed. The left arrow (red) indicate the bladder 
and the right arrow (blue) revealed an oval 
radiopaque structures at the caudal region of the 
abdominal cavity suspicious of prostate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The two-headed arrow shows the pubic-sacral 
promontory distance in a lateral radiographic view. 
The enlarged radiopaque structure (in white circle) 
suspected likely to be the enlarged prostate which 
occupied more than 70% of the pubic-sacral 
promontory distance. 
 
 
 
urinary tract. Thus, cystolithiasis and urolithiasis were 
ruled out in this case. 
The prostate gland on the lateral radiographic view 
was considered enlarged as the prostatic diameter was 
greater than 70% of the pubic-sacral promontory distance 
(Figure 3) (Johnston et al., 2000).  
Abdominal ultrasonography was performed further 
evaluate the urinary bladder and the prostate. Findings 
revealed a normal sized of 2cm x 4cm urinary bladder 
with a smooth bladder wall and no sediment. Hence, 
urinary bladder neoplasia was unlikely. A hypoechoic 
structure measured 3cm x 4cm in size was noticed on the 
right lobe of prostate gland, which was suggestive of a 
cyst. An ultrasound-guided fine needle aspiration of the 
suspected prostate cyst was conducted and approximately 
4 ml of pale yellow fluid was aspirated. Cytology 
examination of the fluid showed clusters of uniform and 
well-differentiated epithelial cells which was suggestive 
of hyperplasia (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Cytology findings of uniform and well-
differentiated epithelial cells (arrow) which was 
suggestive of hyperplasia from fluid aspirated by 
ultrasound-guided fine needle aspiration. 
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Combination of all the findings from physical 
examination, urinalysis, abdominal radiography, 
abdominal ultrasound and fluid cytology, the dog was 
diagnosed with cystic benign prostatic hyperplasia. 
Surgical intervention was opted. Prostatic omentalisation 
and castration were performed for this case. Prostatic 
omentalisation was opted to prevent further cavitary 
lesion such as cyst in this case.  
Upon hospitalisation, the dog was medicated with 
serratiopeptidase (Danzen, Takeda, Japan) as an anti-
inflammatory and 5 mg/kg enrofloxacin (Batyril®, Bayer, 
USA) as prophylactic antibiotic therapy. Vitamin B 
complex was administered orally as appetite stimulant. 
3mg/kg of tramadol hydrochloride (Acugesic, CCM 
Duopharma BioTech, Malaysia) was administered 
intravenously as an analgesic after the surgery. Condition 
of the dog improved on the first day post-surgery where 
haematuria was no longer observed. Other clinical signs 
such as stranguria and tenesmus were no longer present 
and the dog did not show any abdominal discomfort upon 
palpation.  
 
DISCUSSION 
 
The common clinical signs observed in dogs with 
benign prostatic hyperplasia are dripping of prostatic 
sanguineous fluid from the penile tip, haematuria, 
stranguria and constipation (Johnston et al., 2000). 
Haemospermia and tenesmus may also be seen in some 
dogs with benign prostatic hyperplasia (Johnston et al., 
2000). The other prostatic disease that need to be 
differentiate from benign prostatic hyperplasia are 
prostatitis, prostatic abscesses, prostatic cysts, and 
prostatic neoplasia, where are uncommonly presented in 
dogs (Smith, 2008). 
Pathophysiology of benign prostatic hyperplasia is 
not fully known, and it has been speculated to be due to 
increase in responsiveness of the prostate gland toward 
testosterone and/or affected by the altered 
androgen:oestrogen ratio secreted by testes (Leib and 
Monroe, 1997). Testosterone serves as prohormone for 
dihydrotestosterone. Increased dihydrotestosterone level 
will result in symmetric, progressive, eccentric, and 
prostatic parenchymal hyperplasia (Davidson, 2014). 
Apart from dihydrotestosterone, benign prostatic 
hyperplasia is also facilitated by oestrogen. Oestrogen 
will enhance androgen receptors in the gland, 
predisposing the gland to higher risk of undergoing 
hyperplasia (Leib and Monroe, 1997). 
Cyst formation may occur if there is an obstruction 
of the prostatic canaliculi resulting in accumulation of 
prostatic fluid. There are two types of prostatic cyst, 
which are prostatic retention cyst and paraprostatic cyst. 
These two types of cysts can be differentiated by 
comparing the location and structural communication 
with the prostatic urethral. Prostatic retention cyst is 
usually located within the prostatic parenchymal with 
cavitating lesion filled with fluid (Smith, 2008) and often 
there will be communication between the cysts with 
prostatic urethra (White, 2000). Paraprostatic cyst is 
usually located outside the gland and has minimal 
communication with the prostatic urethra (White, 2000) 
which occurred in this case.  
There are a few treatment options available for 
benign prostatic hyperplasia, both medically and 
surgically. However, prostatic diseases commonly 
warrant surgical intervention. Early castration may 
prevent the development of benign prostatic hyperplasia, 
prostatitis, and cavitary lesions (prostatic abscesses or 
cysts). In intact dogs that present with these disorders, 
castration is commonly recommended as treatment or as a 
prevention measure for the occurrences of this disease 
especially in old dogs. Castration should always be part 
of the specific surgical treatment because it enhances 
treatment success and may prevent recurrence. Castration 
will remove the influence of hormones on the prostate 
gland, resulting in up to 70% reduction in size of the 
gland in a dog with benign prostatic hyperplasia (Smith, 
2008). The current treatment of choice for cavitary 
lesions is prostatic omentalisation, which results in lower 
postoperative mortality, faster recovery, and fewer 
incidences of recurrence than other prostatic drainage 
techniques. Prostatic omentalisation can be performed as 
surgical treatment to place the omentum on the prostatic 
lesion. Function of omentum is to promote angiogenesis, 
enhance lymphatic drainage, phagocytic functions, and 
promote localised adhesion (White, 2000). Prostatic 
omentalisation is categorised into intracapsular or 
extracapsular (Freitag et al., 2007). Omentum is placed 
into the prostate along or surrounding the prostatic 
urethra in intracapsular prostatic omentalisation. On the 
other hand, omentum is packed loosely into the cyst 
cavity and sutured to the cyst remnant for extracapsular 
prostatic omentalisation (Freitag et al., 2007). 
Surgical intervention is often not a favourable 
option among dog breeders. In such cases, administration 
of finasteride would be a better medical treatment option. 
Finasteride is a synthetic steroid that blocks the pathway 
which converts testosterone to dihydrotestosterone (Leib 
and Monroe, 1997). Therefore, it inhibits the production 
of dihydrotestosterone and preventsprostatic gland 
hyperplasia. Although the drug may cause reduction in 
the semen volume, the quality and quantity of the semen 
are not affected (Smith, 2008). Another option of 
therapeutic drug is an anti-oestrogenic compound known 
as tamoxifen. Tamoxifen has a mixed antagonist-agonist 
effect and works by blocking the oestrogen receptors in 
the gland (Smith, 2008). This drug has been shown 
effectively reducing the size of prostate gland and 
testosterone concentration in the dogs without any side 
effects (Smith, 2008). However, Tamoxifen is not 
available in Malaysia.  
Surgical intervention of castration and 
omentalization was chosen in this case as it provides the 
best chances of recovery and prevent the risk of disease 
reoccurrence. In addition, total excision paraprostatic cyst 
was recommended as persisting cyst may cause physical 
displacement of abdominal viscera (Johnston et al., 
2000). Apart from unavailability of Tamoxifen in 
Malaysia, finasteride would require a treatment period of 
16 weeks to reduce the prostate size while 
diethystilbestrol and medroxyprogesterone acetate were 
reported of causing adverse effects such as bone marrow 
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suppression, pancytopenia, squamous metaplasia of the 
prostate, and development of diabetes mellitus and 
mammary nodules (Johnston et al., 2000).  
 
CONCLUSION  
 
Benign prostatic hyperplasia is a common disorder 
in old intact male dogs. In some cases, prostatic cysts 
may develop due to canaliculi obstruction leading to 
cystic benign prostatic hyperplasia. As prevention or 
treatment, owners should consider castrating their dogs in 
order to remove the hormones influence on the prostate 
gland. Alternative, finasteride is a good option to be 
considered when surgical intervention is not an option. 
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